BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $104,923 | $110,643 | $304,767 | $504,389 |
| Short-Term Investments | $216,137 | $278,344 | $119,543 | $3,212 |
| Receivables | $79,069 | $56,950 | $50,599 | $29,413 |
| Inventory | $8,087 | $28,683 | $27,533 | $15,791 |
| Other Curr. Assets | $13,752 | $21,346 | $14,058 | $13,331 |
| Total Curr. Assets | $421,968 | $495,966 | $516,500 | $566,136 |
| Property Plant & Equip (Net) | $19,785 | $20,914 | $8,617 | $15,186 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $21,723 | $0 | $18,077 | $6,829 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $26,944 | $80 | $6,806 | $0 |
| Total NC Assets | $68,452 | $20,994 | $33,500 | $22,015 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $490,420 | $516,960 | $550,000 | $588,151 |
| Liabilities | – | – | – | – |
| Payables | $11,644 | $20,893 | $14,356 | $27,808 |
| Short-Term Debt | $35,448 | $2,648 | $2,369 | $1,819 |
| Tax Payable | $0 | $0 | $410 | $2,622 |
| Deferred Revenue | $0 | $0 | $1,224 | $1,421 |
| Other Curr. Liab. | $113,292 | $126,447 | $87,155 | $70,048 |
| Total Curr. Liab. | $160,384 | $149,988 | $105,514 | $103,718 |
| LT Debt | $805,970 | $822,500 | $739,083 | $591,419 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $805,970 | $822,500 | $739,083 | $591,419 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10,048 | $13,883 | $8,173 | $7,781 |
| Total Liabilities | $966,354 | $972,488 | $844,597 | $695,137 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,085 | $2,058 | $1,879 | $1,843 |
| Retained Earnings | -$1,770,040 | -$1,681,159 | -$1,454,620 | -$1,207,504 |
| AOCI | $921 | $1,337 | $26 | $177 |
| Other Equity | $1,291,100 | $1,222,236 | $1,158,118 | $1,098,498 |
| Total Equity | -$475,934 | -$455,528 | -$294,597 | -$106,986 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $490,420 | $516,960 | $550,000 | $588,151 |
| Net Debt | $736,495 | $714,505 | $436,685 | $88,849 |